Think Forward with Clarivate AI
Searching for the latest news and insights on the red-hot topic of Artificial Intelligence?? Look no further than the Think Forward with Clarivate AI monthly newsletter
How AI is starting to help solve top challenges facing the healthcare and life science industry
AI is beginning to play a role in driving medical breakthroughs, but the full promise of AI in healthcare remains a mystery. In a wide-ranging TV interview, Rob Poolman, a leader in life sciences and healthcare at Clarivate provides three specific examples of AI-powered advances coming to the healthcare sector. For instance, AI-powered solutions are being used to suggest new drugs for the treatment of patients with a particular disease. AI is also helping to screen out drug candidates as well.?
TV interview: “AI leadership insights: applying AI to healthcare”?
A trillion pixel problem: how AI is posing fundamental questions to IP laws?
Defining what is meant by “intellect,” and who or what can own it, are basic legal questions that confront the IP sector. With the coming of AI, these questions affect almost all classes of intellectual property. However, arguably the biggest challenge in IP – due to its potential reach to everybody – lies in the creative space, particularly in copyright laws, according to two leading IP experts from Clarivate.??
Blog: “A trillion pixel problem”??
From lab to life: the transformative power of synthetic biology?
Rapid advances in technology and science are shaping a new era, with AI and synthetic biology, or “syn-bio,” leading the way.? In the latest episode of the Ideas to Innovation Season 3 podcast from Clarivate, Citation Laureate Jim Collins, a trailblazer in syn-bio, reveals how it promises to unravel solutions to the world’s most pressing challenges, including Earth’s food and water, the environment and sustainability, bioenergy, and human healthcare.??
领英推荐
Expanding partnership offers new solution to accelerate and de-risk research and drug development?
Clarivate has announced the launch of VeriSIM Life Translational Index ? on Cortellis Drug Discovery Intelligence by Clarivate. The new solution serves as the next phase in a growing partnership between Clarivate and VeriSIM Life, the leading AI-enabled R&D decisions de-risker for breakthrough drug development. The solution offers a seamless, integrated approach for drug program owners at pharma and biopharma organizations to better manage the risk of asset development.?
News release: “Clarivate expands partnership with VeriSIM Life.”?
New report identifies the 128 most active or rapidly developing areas in science and social sciences?
In their latest joint report, Clarivate and the Chinese Academy of Sciences have unveiled the latest progress and evolving direction of scientific fields by identifying significant research specialties and social sciences. A total of 128 Research Fronts were identified in this year’s report, including, for example, the fast-evolving influence of AI in environmental sciences.??
News release: “Clarivate and the Chinese Academy of Sciences release annual report to identify 128 research fronts”??
AI-driven breakthroughs in drug discovery and development are winning big pharma’s attention?
Over the past decade, the number of AI companies involved in drug discovery and development has increased dramatically. According to one Clarivate expert, big pharma AI deals are a major trend in the life sciences and healthcare sector. The reason? Industry giants such as Sanofi, Pfizer, Novo Nordisk and Merck seek access to technologies and platforms that can help them facilitate the next generation of innovative therapeutics.??